First AD

Second AD

CAR T-Cell Therapy for B-ALL: Roles Within the Multidisciplinary Care Team

Video content above is prompted by the following:

Please briefly describe your distinct roles with patient eligibility for CAR T-cell therapy treatment, management, and follow-up in adult patients with precursor B-ALL.

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Video Series

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

A Multidisciplinary Approach to CAR T-cell Therapy for Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia 

OncLive Insights

Experts discuss their distinct roles in patient eligibility, management, and follow-up for chimeric antigen receptor (CAR) T-cell therapy treatment in adult patients with precursor B-cell acute lymphoblastic leukemia (B-ALL), focusing on assessment, treatment planning, and ongoing care.